Trial Details
TERMINATEDBasic Information
| Clinical ID | c4501 |
|---|---|
| Identifier | NCT00417690 |
| Trial Title | High Dose Oral 4-Aminosalicylic Acid (PASER®) to Control Acute Flares of Mild to Moderate Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: 4-Aminosalicylic acid|DRUG: PASER placebo granules |
Participant Information
| Sponsor | Jacobus Pharmaceutical |
|---|---|
| City | Chicago |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2007-01 |
|---|---|
| Primary Completion Date | 2007-12 |
| Completion Date | 2008-10 |